SU1165223A3 - Способ получени эргоалкалоидов - Google Patents

Способ получени эргоалкалоидов Download PDF

Info

Publication number
SU1165223A3
SU1165223A3 SU762412401A SU2412401A SU1165223A3 SU 1165223 A3 SU1165223 A3 SU 1165223A3 SU 762412401 A SU762412401 A SU 762412401A SU 2412401 A SU2412401 A SU 2412401A SU 1165223 A3 SU1165223 A3 SU 1165223A3
Authority
SU
USSR - Soviet Union
Prior art keywords
ergoalkaloids
methanesulfonate
mixture
fact
flask
Prior art date
Application number
SU762412401A
Other languages
English (en)
Russian (ru)
Inventor
Эрхардт Лотар
Хартманн Фолькер
Патт Людвиг
Отто Карл-Хайнц
Original Assignee
Сандос Аг (Фирма)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Сандос Аг (Фирма) filed Critical Сандос Аг (Фирма)
Application granted granted Critical
Publication of SU1165223A3 publication Critical patent/SU1165223A3/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/48Ergoline derivatives, e.g. lysergic acid, ergotamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SU762412401A 1975-10-17 1976-10-15 Способ получени эргоалкалоидов SU1165223A3 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2546577A DE2546577B2 (de) 1975-10-17 1975-10-17 Feste Stoffe aus Polyvinylpyrrolidon und Ergotalkaloiden

Publications (1)

Publication Number Publication Date
SU1165223A3 true SU1165223A3 (ru) 1985-06-30

Family

ID=5959411

Family Applications (1)

Application Number Title Priority Date Filing Date
SU762412401A SU1165223A3 (ru) 1975-10-17 1976-10-15 Способ получени эргоалкалоидов

Country Status (28)

Country Link
JP (1) JPS5854122B2 (es)
AT (1) AT362510B (es)
AU (1) AU508628B2 (es)
BE (1) BE847368A (es)
CA (1) CA1079641A (es)
CH (1) CH643737A5 (es)
CS (1) CS199647B2 (es)
DE (1) DE2546577B2 (es)
DK (1) DK146194C (es)
ES (1) ES452420A1 (es)
FI (1) FI762875A (es)
FR (1) FR2327764A1 (es)
GB (1) GB1560406A (es)
GR (1) GR61268B (es)
HK (1) HK3183A (es)
HU (1) HU172533B (es)
IE (1) IE43778B1 (es)
IL (1) IL50686A (es)
MY (1) MY8400063A (es)
NL (1) NL184558C (es)
NO (1) NO144468C (es)
NZ (1) NZ182341A (es)
PH (1) PH14513A (es)
PT (1) PT65719B (es)
SE (1) SE430379B (es)
SG (1) SG63082G (es)
SU (1) SU1165223A3 (es)
ZA (1) ZA766166B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1572226A (en) * 1977-11-03 1980-07-30 Hoechst Uk Ltd Pharmaceutical preparations in solid unit dosage form
US4411882A (en) 1978-12-21 1983-10-25 Sandoz Ltd. Galenical compositions
WO1980001242A1 (en) * 1978-12-21 1980-06-26 Sandoz Ag Galenical preparation
FR2454804B1 (fr) * 1979-04-26 1986-11-21 Sanofi Sa Medicament a base de dihydroergotoxine et son procede de preparation
US4366145A (en) * 1981-06-24 1982-12-28 Sandoz, Inc. Soft gelatin capsule with a liquid ergot alkaloid center fill solution and method of preparation
US4898729A (en) * 1983-12-09 1990-02-06 Euroceltique, S.A. Treatment of hypertension, compounds and compositions for antihypertension and diuresis
NL194389C (nl) * 1984-06-14 2002-03-04 Novartis Ag Werkwijze voor het bereiden van een vaste dispersie van een farmaceutisch actief middel dat een lage oplosbaarheid in water heeft, in een vaste matrix van een in water oplosbaar polyalkyleenglycol als drager.
EP0277092B1 (de) * 1987-01-14 1992-01-29 Ciba-Geigy Ag Therapeutisches System für schwerlösliche Wirkstoffe
FR2610827B1 (fr) * 1987-02-18 1991-09-13 Pf Medicament Comprime de dihydroergotamine (d.h.e.) du type a matrice hydrophile et son procede de fabrication
US5064656A (en) * 1989-11-14 1991-11-12 Dr. Gergely & Co. Uncoated pharmaceutical reaction tablet
DE4401646A1 (de) * 1994-01-21 1995-07-27 Krewel Werke Gmbh Optimal freisetzende Kava-Extrakte
US6524832B1 (en) 1994-02-04 2003-02-25 Arch Development Corporation DNA damaging agents in combination with tyrosine kinase inhibitors
US6632455B2 (en) 1997-12-22 2003-10-14 Schering Corporation Molecular dispersion composition with enhanced bioavailability
CO4970793A1 (es) * 1997-12-22 2000-11-07 Schering Corp Composicion para dispersion molecular con biodisponibilidad aumentada
US6316462B1 (en) 1999-04-09 2001-11-13 Schering Corporation Methods of inducing cancer cell death and tumor regression
US7771746B2 (en) 1999-12-03 2010-08-10 Polichem Sa Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
JP4965784B2 (ja) * 1999-12-03 2012-07-04 ポリケム・ソシエテ・アノニム バイオアベイラビリティの向上した麦角アルカロイドの徐放性医薬組成物の製造法及びその組成物
US7135436B2 (en) 2003-05-05 2006-11-14 J.F. Daley International, Ltd. Solid algicide, preparation and usage in recirculating water
PT1638527E (pt) * 2003-06-27 2007-02-28 Bioprogress Spa Produto compósito obtido por co-trituração de um princípio activo com um copolímero de n-vinil-2-pirrolidona/acetato de vinilo

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1175430A (en) * 1966-04-07 1969-12-23 Sandoz Ltd Pharmaceutical Compositions containing Ergot Alkaloids

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Патент US 3146169, кл. 424-15, 1962. *

Also Published As

Publication number Publication date
FI762875A (es) 1977-04-18
PT65719A (fr) 1976-11-01
IE43778L (en) 1977-04-17
DK454176A (da) 1977-04-18
IL50686A (en) 1979-05-31
AT362510B (de) 1981-05-25
IL50686A0 (en) 1976-12-31
DE2546577B2 (de) 1981-04-02
AU1875476A (en) 1978-04-20
NZ182341A (en) 1978-09-20
DK146194B (da) 1983-07-25
IE43778B1 (en) 1981-05-20
ATA767976A (de) 1980-10-15
NL184558C (nl) 1989-09-01
CS199647B2 (en) 1980-07-31
NL184558B (nl) 1989-04-03
ZA766166B (en) 1978-05-30
AU508628B2 (en) 1980-03-27
GB1560406A (en) 1980-02-06
ES452420A1 (es) 1978-04-16
JPS5251014A (en) 1977-04-23
CA1079641A (en) 1980-06-17
MY8400063A (en) 1984-12-31
NL7611295A (nl) 1977-04-19
JPS5854122B2 (ja) 1983-12-02
DE2546577A1 (de) 1977-04-21
DK146194C (da) 1984-01-02
FR2327764A1 (fr) 1977-05-13
NO144468C (no) 1981-09-09
SE7611189L (sv) 1977-04-18
SE430379B (sv) 1983-11-14
CH643737A5 (en) 1984-06-29
BE847368A (fr) 1977-04-15
GR61268B (en) 1978-10-17
NO144468B (no) 1981-06-01
PH14513A (en) 1981-08-24
FR2327764B1 (es) 1979-03-02
PT65719B (fr) 1978-06-12
NO763446L (es) 1977-04-19
SG63082G (en) 1983-09-09
HU172533B (hu) 1978-09-28
HK3183A (en) 1983-01-20

Similar Documents

Publication Publication Date Title
SU1165223A3 (ru) Способ получени эргоалкалоидов
US8058433B2 (en) Crystalline pharmaceutical
KR100664560B1 (ko) L(-)-카르니틴의 비흡습성 염을 제조하는 신규한 방법
KR950006710B1 (ko) 암로디핀의 베실레이트염의 제조방법
FI119639B (fi) Menetelmä kiteisen vedettömän mykofenolaattimofetiilin ja sen intravenoosivalmisteen valmistamiseksi
EP0265226B1 (en) Spray dried acetaminophen
RU2002745C1 (ru) Способ получени кристаллов дигидрата гидрохлорида ондансетрона уменьшенного размера
FI70138C (fi) Foerfarande foer framstaellning av en foerbaettrad injekterbarloesning innehaollande kalcium/magnesium/oxitetracyklinsa mklat
AU2006222711A1 (en) Crystalline pharmaceutical
IE41573B1 (en) Pharmaceutical compositions
AU2001250920A1 (en) Crystalline pharmaceutical
US4222939A (en) Process for preparing solid sodium amoxycillin
SU1053748A3 (ru) Способ получени тетрагидро 2 @ бензо-/ @ /-пиррола
KR100295255B1 (ko) 피롤리디닐메틸인돌의염
WO2004011432A1 (en) Organic acid salt of amlodipine
KR950007228B1 (ko) 암로디핀의 베실레이트염
RU2042686C1 (ru) Кристаллический этопозид 4`-фосфат диэтанолсольват и способ его получения
SU648101A3 (ru) Способ получени стабильной полиморфной формы 1-окси-3-(1,1-диметилгептил)-6,6-диметил-6,6а,7,8,10,10агексагидро-9н-дибензо (в, ) пиран9-она
CN116947850A (zh) 一种盐酸小檗碱与间羟基苯甲酸共晶及其制备方法
WO2014023647A1 (en) Bortezomib esters and formulations thereof
SU537070A1 (ru) Диметилбензосульфонат кускгигрина в качестве ганглиоблокатора кратковременного действи
ZA200206962B (en) Crystalline pharmaceutical.
KR19990084651A (ko) 안정성이 향상된 미소프로스톨 제제 및 그 제조방법